Status Unknown

Phase 2
Age: 18Years +
All Genders
ID00002414

Randomized, Double-Blind, Parallel Group, Placebo Controlled, Tolerability, Safety and Pilot Efficacy Study of CPI-1189 in HIV Infected Individuals With Cognitive and Motor Impairment

Led by Centaur Pharmaceuticals · Updated on 2005-06-24

60

Participants Needed

6

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to see if it is safe and effective to give CPI-1189 to patients with AIDS dementia. Advanced HIV infection can cause AIDS dementia (brain damage due to HIV leading to loss of memory and muscle control). CPI-1189 may be able to postpone AIDS dementia or slow it down.

CONDITIONS

Official Title

Safety and Effectiveness of Giving CPI-1189 to HIV-Infected Patients With AIDS Dementia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Inclusion Criteria

You may be eligible for this study if you:

  • Are HIV-positive.
  • Are at least 18 years old.
  • Have symptoms of AIDS dementia including forgetfulness, loss of concentration, slow mental processing, or a loss of muscle control.
  • Have been on stable anti-HIV drug therapy for the past 6 weeks (if you are taking anti-HIV drugs).

Exclusion Criteria

You will not be eligible for this study if you:

  • Have certain serious medical conditions, such as a mental disorder or an opportunistic (AIDS-related) infection.
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 6 locations

1

Alzheimers Disease Research Ctr 0948 / UCSD

San Diego, California, United States, 920930948

Status Unknown

2

Northwestern Univ / Dept of Neurology

Chicago, Illinois, United States, 60611

Status Unknown

3

Johns Hopkins Hosp / Dept of Neurology / Meyer 6109

Baltimore, Maryland, United States, 212877609

Status Unknown

4

Washington Univ Sch of Med / Dept of Neurology

St Louis, Missouri, United States, 63110

Status Unknown

5

Columbia Univ / Sergievsky Ctr Physicians and Surgeons

New York, New York, United States, 10032

Status Unknown

6

Univ of Rochester / Strong Memorial Hosp

Rochester, New York, United States, 14620

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

N/A

Model

N/A

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial